The second installment of Cancer Research Catalyst’s new monthly series, “Unboxing Cancer News,” highlights exciting cancer research discoveries reported during September, including the effects of early-life sugar restriction on cancer risk, the potential of...
A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy. Personalized immunotherapies are an emerging treatment approach that directs the patient’s immune response to target their unique cancer. To design...
During the opening plenary session of the AACR Special Conference in Cancer Research: Bridging Discovery and Clinical Impact in Pediatric Cancer, the keynote presenter, Charles Mullighan, MBBS (Hons), MSc, MD, and the 2025 AACR-St....
Could higher rates of binge drinking be contributing to an increase in early-onset cancers? Mary Beth Terry, PhD, of Columbia University; Yin Cao, ScD, MPH, of Washington University School of Medicine in St. Louis;...
An FDA committee supports a liquid biopsy that screens for up to 50 cancers, and the FDA approves a drug combo for certain people with breast cancer.
Carolyn Searles and her sisters all tested positive for a BRCA1 mutation and underwent double mastectomies to reduce their breast cancer risk. Still, Carolyn was diagnosed with breast cancer while 16 weeks pregnant. Last...
The new combination is approved for patients with advanced clear cell renal cell carcinoma that progressed on or after certain immune checkpoint inhibitors. The U.S. Food and Drug Administration (FDA) has approved belzutifan (Welireg)...
Around a hundred early-career clinicians and researchers from Ukraine and Poland attended last month’s AACR on Campus event in Warsaw, held in partnership with the Maria Skłodowska-Curie National Research Institute of Oncology and the...
AACR and Kids Beating Cancer have announced a new grant to support pediatric leukemia research, with a particular focus on high-risk acute myeloid leukemia subtypes at the AACR Special Conference in Cancer Research: Bridging...
This year’s Party with a Purpose, hosted by the Friends of the AACR Foundation, will honor Robert H. Vonderheide, MD, DPhil, FAACR, and Andrew Rech, MD, PhD, of the University of Pennsylvania, for their...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More